What is he best known for?
The fields of study he is best known for:
- Surgery
- Internal medicine
- Cancer
His main research concerns Surgery, Nephrectomy, Urology, Carcinoma and Renal cell carcinoma.
His research in Surgery intersects with topics in Prostate cancer, Cumulative incidence and Adenocarcinoma.
His research investigates the connection with Nephrectomy and areas like Kidney disease which intersect with concerns in Radiology and Creatinine.
The Urology study combines topics in areas such as Prostate-specific antigen, Prostatectomy and Univariate analysis.
His Carcinoma study is associated with Pathology.
Horst Zincke focuses mostly in the field of Renal cell carcinoma, narrowing it down to matters related to Cancer and, in some cases, Survival analysis.
His most cited work include:
- An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. (869 citations)
- Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. (848 citations)
- Solid Renal Tumors: An Analysis of Pathological Features Related to Tumor Size (803 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Surgery, Urology, Prostate cancer, Prostatectomy and Internal medicine.
Horst Zincke combines subjects such as Renal cell carcinoma and Nephrectomy with his study of Surgery.
His Urology study combines topics in areas such as Transitional cell carcinoma, Cancer, Biopsy and Proportional hazards model.
His studies deal with areas such as Survival analysis and Radiation therapy as well as Prostate cancer.
His Prostatectomy research is multidisciplinary, relying on both Hormonal therapy and Adjuvant therapy.
His Internal medicine research integrates issues from Gastroenterology and Oncology.
He most often published in these fields:
- Surgery (43.71%)
- Urology (39.36%)
- Prostate cancer (30.89%)
What were the highlights of his more recent work (between 2003-2011)?
- Urology (39.36%)
- Internal medicine (24.03%)
- Surgery (43.71%)
In recent papers he was focusing on the following fields of study:
Horst Zincke spends much of his time researching Urology, Internal medicine, Surgery, Prostate cancer and Renal cell carcinoma.
His work deals with themes such as Survival rate, Cystectomy, Biopsy and Doubling time, which intersect with Urology.
Within one scientific family, Horst Zincke focuses on topics pertaining to Nephron sparing surgery under Surgery, and may sometimes address concerns connected to Renal function and General surgery.
His Prostate cancer study incorporates themes from Prostate and Radiation therapy.
Horst Zincke interconnects Carcinoma, Nephrectomy and Kidney disease in the investigation of issues within Renal cell carcinoma.
His work in Prostatectomy addresses issues such as Prostate-specific antigen, which are connected to fields such as Hormonal therapy.
Between 2003 and 2011, his most popular works were:
- Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up. (729 citations)
- Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy (497 citations)
- Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate‐specific antigen testing: 15‐year outcome (385 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Cancer
Surgery, Internal medicine, Nephrectomy, Renal cell carcinoma and Carcinoma are his primary areas of study.
His Surgery study integrates concerns from other disciplines, such as Prostatectomy, Prostate cancer and Urology.
He combines subjects such as Prostate-specific antigen and Prostate with his study of Urology.
His study in Nephrectomy is interdisciplinary in nature, drawing from both Primary tumor and Complication.
As a part of the same scientific study, Horst Zincke usually deals with the Renal cell carcinoma, concentrating on Cancer and frequently concerns with Univariate analysis.
His Carcinoma research includes elements of Clear cell renal cell carcinoma and Adenocarcinoma.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
